Exact Mass: 445.1849
Exact Mass Matches: 445.1849
Found 500 metabolites which its exact mass value is equals to given mass value 445.1849
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Narceine
Narceine is found in opium poppy. Narceine is an alkaloid from Papaver somniferum (opium poppy C78272 - Agent Affecting Nervous System > C67413 - Opioid Receptor Agonist Narceine is a stilbenoid.
Tetrahydrofolic acid
Tetrahydrofolate is a soluble coenzyme (vitamin B9) that is synthesized de novo by plants and microorganisms, and absorbed from the diet by animals. It is composed of three distinct parts: a pterin ring, a p-ABA (p-aminobenzoic acid) and a polyglutamate chain with a number of residues varying between 1 and 8. Only the tetra-reduced form of the molecule serves as a coenzyme for C1 transfer reactions. In biological systems, the C1-units exist under various oxidation states and the different tetrahydrofolate derivatives constitute a family of related molecules named indistinctly under the generic term folate. (PMID 16042593). Folate is important for cells and tissues that rapidly divide. Cancer cells divide rapidly, and drugs that interfere with folate metabolism are used to treat cancer. Methotrexate is a drug often used to treat cancer because it inhibits the production of the active form, tetrahydrofolate. Unfortunately, methotrexate can be toxic, producing side effects such as inflammation in the digestive tract that make it difficult to eat normally. -- Wikipedia; Signs of folic acid deficiency are often subtle. Diarrhea, loss of appetite, and weight loss can occur. Additional signs are weakness, sore tongue, headaches, heart palpitations, irritability, and behavioral disorders. Women with folate deficiency who become pregnant are more likely to give birth to low birth weight and premature infants, and infants with neural tube defects. In adults, anemia is a sign of advanced folate deficiency. In infants and children, folate deficiency can slow growth rate. Some of these symptoms can also result from a variety of medical conditions other than folate deficiency. It is important to have a physician evaluate these symptoms so that appropriate medical care can be given. -- Wikipedia; Folinic acid is a form of folate that can help rescue or reverse the toxic effects of methotrexate. Folinic acid is not the same as folic acid. Folic acid supplements have little established role in cancer chemotherapy. There have been cases of severe adverse effects of accidental substitution of folic acid for folinic acid in patients receiving methotrexate cancer chemotherapy. It is important for anyone receiving methotrexate to follow medical advice on the use of folic or folinic acid supplements. -- Wikipedia. Low concentrations of folate, vitamin B12, or vitamin B6 may increase the level of homocysteine, an amino acid normally found in blood. There is evidence that an elevated homocysteine level is an independent risk factor for heart disease and stroke. The evidence suggests that high levels of homocysteine may damage coronary arteries or make it easier for blood clotting cells called platelets to clump together and form a clot. However, there is currently no evidence available to suggest that lowering homocysteine with vitamins will reduce your risk of heart disease. Clinical intervention trials are needed to determine whether supplementation with folic acid, vitamin B12 or vitamin B6 can lower your risk of developing coronary heart disease. -- Wikipedia. Tetrahydrofolate is a soluble coenzyme (vitamin B9) that is synthesized de novo by plants and microorganisms, and absorbed from the diet by animals. It is composed of three distinct parts: a pterin ring, a p-ABA (p-aminobenzoic acid) and a polyglutamate chain with a number of residues varying between 1 and 8. Only the tetra-reduced form of the molecule serves as a coenzyme for C1 transfer reactions. In biological systems, the C1-units exist under various oxidation states and the different tetrahydrofolate derivatives constitute a family of related molecules named indistinctly under the generic term folate. (PMID 16042593)
Fumiquinazoline A
A fumiquinazoline that consists of imidazoindole and pyrazinoquinazoline units connected by a methylene group.
tridihexethyl iodide
C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent
cerdulatinib
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor
Tak-593
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor > C93259 - VEGFR Tyrosine Kinase Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163953 - VEGFR-targeting Agent C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor
glipizide
A - Alimentary tract and metabolism > A10 - Drugs used in diabetes > A10B - Blood glucose lowering drugs, excl. insulins > A10BB - Sulfonylureas C78276 - Agent Affecting Digestive System or Metabolism > C29711 - Anti-diabetic Agent > C97936 - Sulfonylurea Antidiabetic Agent D007004 - Hypoglycemic Agents CONFIDENCE standard compound; INTERNAL_ID 467; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4274; ORIGINAL_PRECURSOR_SCAN_NO 4271 CONFIDENCE standard compound; INTERNAL_ID 467; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4287; ORIGINAL_PRECURSOR_SCAN_NO 4286 CONFIDENCE standard compound; INTERNAL_ID 467; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4253; ORIGINAL_PRECURSOR_SCAN_NO 4250 CONFIDENCE standard compound; INTERNAL_ID 467; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4272; ORIGINAL_PRECURSOR_SCAN_NO 4269 CONFIDENCE standard compound; INTERNAL_ID 467; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4267; ORIGINAL_PRECURSOR_SCAN_NO 4265 CONFIDENCE standard compound; INTERNAL_ID 467; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4263; ORIGINAL_PRECURSOR_SCAN_NO 4262 CONFIDENCE standard compound; INTERNAL_ID 467; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8486; ORIGINAL_PRECURSOR_SCAN_NO 8483 CONFIDENCE standard compound; INTERNAL_ID 467; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8521; ORIGINAL_PRECURSOR_SCAN_NO 8519 CONFIDENCE standard compound; INTERNAL_ID 467; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8531; ORIGINAL_PRECURSOR_SCAN_NO 8530 CONFIDENCE standard compound; INTERNAL_ID 467; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8569; ORIGINAL_PRECURSOR_SCAN_NO 8565 CONFIDENCE standard compound; INTERNAL_ID 467; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8574; ORIGINAL_PRECURSOR_SCAN_NO 8570 CONFIDENCE standard compound; INTERNAL_ID 467; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8577; ORIGINAL_PRECURSOR_SCAN_NO 8573
Glipizide
Glipizide is only found in individuals that have used or taken this drug. It is an oral hypoglycemic agent which is rapidly absorbed and completely metabolized. [PubChem]Sulfonylureas likely bind to ATP-sensitive potassium-channel receptors on the pancreatic cell surface, reducing potassium conductance and causing depolarization of the membrane. Depolarization stimulates calcium ion influx through voltage-sensitive calcium channels, raising intracellular concentrations of calcium ions, which induces the secretion, or exocytosis, of insulin. A - Alimentary tract and metabolism > A10 - Drugs used in diabetes > A10B - Blood glucose lowering drugs, excl. insulins > A10BB - Sulfonylureas C78276 - Agent Affecting Digestive System or Metabolism > C29711 - Anti-diabetic Agent > C97936 - Sulfonylurea Antidiabetic Agent D007004 - Hypoglycemic Agents
Lucuminamide
Lucuminamide is found in fruits. Lucuminamide is a constituent of Calocarpum sapota (marmelade plum)
N-Oxide abiraterone sulfate
N-Oxide abiraterone sulfate is a metabolite of abiraterone. Abiraterone is a drug used in castration-resistant prostate cancer (formerly hormone-resistant or hormone-refractory prostate cancer) (prostate cancer not responding to androgen deprivation or treatment with antiandrogens). It is formulated as the prodrug abiraterone acetate and marketed under the trade name Zytiga. After an expedited six-month review, abiraterone was approved by the U.S. Food and Drug Administration (FDA) in April 2011. (Wikipedia)
5,6,7,8-Tetrahydrofolic acid
Tetrahydrofolate is a soluble coenzyme (vitamin B9) that is synthesized de novo by plants and microorganisms, and absorbed from the diet by animals. It is composed of three distinct parts: a pterin ring, a p-ABA (p-aminobenzoic acid) and a polyglutamate chain with a number of residues varying between 1 and 8. Only the tetra-reduced form of the molecule serves as a coenzyme for C1 transfer reactions. In biological systems, the C1-units exist under various oxidation states and the different tetrahydrofolate derivatives constitute a family of related molecules named indistinctly under the generic term folate. (PMID 16042593)
Glisentide
C78276 - Agent Affecting Digestive System or Metabolism > C29711 - Anti-diabetic Agent > C97936 - Sulfonylurea Antidiabetic Agent
O-Demethyl apixaban
P-Hydroxyhippuryl-his-leu-OH
N-(4-Fluorobenzyl)-3-oxo-1,1-diphenyltetrahydro-1H-oxazolo[3,4-a]pyrazine-7(3H)-carboxamide
tetrahydrofolate
Tetrahydrofolic acid, also known as (6s)-tetrahydrofolate or (6s)-thfa, belongs to glutamic acid and derivatives class of compounds. Those are compounds containing glutamic acid or a derivative thereof resulting from reaction of glutamic acid at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom. Tetrahydrofolic acid is practically insoluble (in water) and a weakly acidic compound (based on its pKa). Tetrahydrofolic acid can be found in a number of food items such as malabar plum, parsnip, white lupine, and alpine sweetvetch, which makes tetrahydrofolic acid a potential biomarker for the consumption of these food products. Tetrahydrofolic acid may be a unique S.cerevisiae (yeast) metabolite. Tetrahydrofolic acid is a drug which is used for nutritional supplementation, also for treating dietary shortage or imbalance. Tetrahydrofolate is transported across cells by receptor-mediated endocytosis where it is needed to maintain normal erythropoiesis, synthesize purine and thymidylate nucleic acids, interconvert amino acids, methylate tRNA, and generate and use formate (DrugBank). COVID info from COVID-19 Disease Map Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
Ala Ile Asn Glu
Ile Ala Gln Asp
Ala Val Gln Glu
Asn Ile Ala Glu
C24H23N5O4_2H-Pyrazino[2,1-b]quinazoline-3,6(1H,4H)-dione, 1-methyl-4-[[(2S,9S,9aS)-2,3,9,9a-tetrahydro-9-hydroxy-2-methyl-3-oxo-1H-imidazo[1,2-a]indol-9-yl]methyl]-, (1S,4R)
C24H23N5O4_2H-Pyrazino[2,1-b]quinazoline-3,6(1H,4H)-dione, 1-methyl-4-[[(2S,9S,9aS)-2,3,9,9a-tetrahydro-9-hydroxy-2-methyl-3-oxo-1H-imidazo[1,2-a]indol-9-yl]methyl]-, (1S,4R)-, (Fumiquinazoline A)
tetrahydrofolic acid
COVID info from COVID-19 Disease Map Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
Ala Cys Pro Arg
Ala Cys Arg Pro
Ala Asp Ile Gln
Ala Asp Leu Gln
Ala Asp Gln Ile
Ala Asp Gln Leu
Ala Glu Ile Asn
Ala Glu Leu Asn
Ala Glu Asn Ile
Ala Glu Asn Leu
Ala Glu Gln Val
Ala Glu Val Gln
Ala Ile Asp Gln
Ala Ile Glu Asn
Ala Ile Gln Asp
Ala Leu Asp Gln
Ala Leu Glu Asn
Ala Leu Asn Glu
Ala Leu Gln Asp
Ala Met Pro Gln
Ala Met Gln Pro
Ala Asn Glu Ile
Ala Asn Glu Leu
Ala Asn Ile Glu
Ala Asn Leu Glu
Ala Asn Asn Gln
Ala Asn Gln Asn
Ala Pro Cys Arg
Ala Pro Met Gln
Ala Pro Gln Met
Ala Pro Arg Cys
Ala Gln Asp Ile
Ala Gln Asp Leu
Ala Gln Glu Val
Ala Gln Ile Asp
Ala Gln Leu Asp
Ala Gln Met Pro
Ala Gln Asn Asn
Ala Gln Pro Met
Ala Gln Val Glu
Ala Arg Cys Pro
Ala Arg Pro Cys
Ala Val Glu Gln
Cys Ala Pro Arg
Cys Ala Arg Pro
Cys Ile Asn Pro
Cys Ile Pro Asn
Cys Leu Asn Pro
Cys Leu Pro Asn
Cys Asn Ile Pro
Cys Asn Leu Pro
Cys Asn Pro Ile
Cys Asn Pro Leu
Cys Pro Ala Arg
Cys Pro Ile Asn
Cys Pro Leu Asn
Cys Pro Asn Ile
Cys Pro Asn Leu
Cys Pro Gln Val
Cys Pro Arg Ala
Cys Pro Val Gln
Cys Gln Pro Val
Cys Gln Val Pro
Cys Arg Ala Pro
Cys Arg Pro Ala
Cys Val Pro Gln
Cys Val Gln Pro
Asp Ala Ile Gln
Asp Ala Leu Gln
Asp Ala Gln Ile
Asp Ala Gln Leu
Asp Ile Ala Gln
Asp Ile Gln Ala
Asp Lys Pro Ser
Asp Lys Ser Pro
Asp Leu Ala Gln
Asp Leu Gln Ala
Asp Asn Pro Thr
Asp Asn Thr Pro
Asp Asn Val Val
Asp Pro Lys Ser
Asp Pro Asn Thr
Asp Pro Gln Ser
Asp Pro Ser Lys
Asp Pro Ser Gln
Asp Pro Thr Asn
Asp Gln Ala Ile
Asp Gln Ala Leu
Asp Gln Ile Ala
Asp Gln Leu Ala
Asp Gln Pro Ser
Asp Gln Ser Pro
Asp Ser Lys Pro
Asp Ser Pro Lys
Asp Ser Pro Gln
Asp Ser Gln Pro
Asp Thr Asn Pro
Asp Thr Pro Asn
Asp Val Asn Val
Asp Val Val Asn
Glu Ala Ile Asn
Glu Ala Leu Asn
Glu Ala Asn Ile
Glu Ala Asn Leu
Glu Ala Gln Val
Glu Ala Val Gln
Glu Gly Ile Gln
Glu Gly Leu Gln
Glu Gly Gln Ile
Glu Gly Gln Leu
Glu Ile Ala Asn
Glu Ile Gly Gln
Glu Ile Asn Ala
Glu Ile Gln Gly
Glu Leu Ala Asn
Glu Leu Gly Gln
Glu Leu Asn Ala
Glu Leu Gln Gly
Glu Asn Ala Ile
Glu Asn Ala Leu
Glu Asn Ile Ala
Glu Asn Leu Ala
Glu Asn Pro Ser
Glu Asn Ser Pro
Glu Pro Asn Ser
Glu Pro Ser Asn
Glu Gln Ala Val
Glu Gln Gly Ile
Glu Gln Gly Leu
Glu Gln Ile Gly
Glu Gln Leu Gly
Glu Gln Val Ala
Glu Ser Asn Pro
Glu Ser Pro Asn
Glu Val Ala Gln
Glu Val Gln Ala
Gly Glu Ile Gln
Gly Glu Leu Gln
Gly Glu Gln Ile
Gly Glu Gln Leu
Gly Ile Glu Gln
Gly Ile Gln Glu
Gly Leu Glu Gln
Gly Leu Gln Glu
Gly Asn Gln Gln
Gly Pro Ser Trp
Gly Pro Trp Ser
Gly Gln Glu Ile
Gly Gln Glu Leu
Gly Gln Ile Glu
Gly Gln Leu Glu
Gly Gln Asn Gln
Gly Gln Gln Asn
Gly Ser Pro Trp
Gly Ser Trp Pro
Gly Trp Pro Ser
Gly Trp Ser Pro
Ile Ala Asp Gln
Ile Cys Asn Pro
Ile Cys Pro Asn
Ile Asn Cys Pro
Ile Asn Pro Cys
Ile Pro Cys Asn
Ile Pro Asn Cys
Leu Cys Asn Pro
Leu Cys Pro Asn
Leu Asn Cys Pro
Leu Asn Pro Cys
Leu Pro Cys Asn
Leu Pro Asn Cys
Met Ala Pro Gln
Met Ala Gln Pro
Met Pro Ala Gln
Met Pro Gln Ala
Met Gln Ala Pro
Met Gln Pro Ala
Asn Ala Asn Gln
Asn Ala Gln Asn
Asn Cys Ile Pro
Asn Cys Leu Pro
Asn Cys Pro Ile
Asn Cys Pro Leu
Asn Asp Pro Thr
Asn Asp Thr Pro
Asn Glu Pro Ser
Asn Glu Ser Pro
Asn Gly Gln Gln
Asn Ile Cys Pro
Asn Ile Pro Cys
Asn Leu Cys Pro
Asn Leu Pro Cys
Asn Asn Ala Gln
Asn Asn Gln Ala
Asn Pro Cys Ile
Asn Pro Cys Leu
Asn Pro Asp Thr
Asn Pro Glu Ser
Asn Pro Ile Cys
Asn Pro Leu Cys
Asn Pro Ser Glu
Asn Pro Thr Asp
Asn Gln Ala Asn
Asn Gln Gly Gln
Asn Gln Asn Ala
Asn Gln Gln Gly
Asn Ser Glu Pro
Asn Ser Pro Glu
Asn Thr Asp Pro
Asn Thr Pro Asp
Pro Ala Cys Arg
Pro Ala Met Gln
Pro Ala Gln Met
Pro Ala Arg Cys
Pro Cys Ala Arg
Pro Cys Ile Asn
Pro Cys Leu Asn
Pro Cys Asn Ile
Pro Cys Asn Leu
Pro Cys Gln Val
Pro Cys Arg Ala
Pro Cys Val Gln
Pro Asp Asn Thr
Pro Asp Gln Ser
Pro Asp Ser Gln
Pro Asp Thr Asn
Pro Glu Asn Ser
Pro Glu Ser Asn
Pro Gly Ser Trp
Pro Gly Trp Ser
Pro Ile Cys Asn
Pro Ile Asn Cys
Pro Leu Cys Asn
Pro Leu Asn Cys
Pro Met Ala Gln
Pro Met Gln Ala
Pro Asn Cys Ile
Pro Asn Cys Leu
Pro Asn Asp Thr
Pro Asn Glu Ser
Pro Asn Ile Cys
Pro Asn Leu Cys
Pro Asn Ser Glu
Pro Asn Thr Asp
Pro Gln Ala Met
Pro Gln Cys Val
Pro Gln Asp Ser
Pro Gln Met Ala
Pro Gln Ser Asp
Pro Gln Val Cys
Pro Arg Ala Cys
Pro Arg Cys Ala
Pro Ser Asp Gln
Pro Ser Glu Asn
Pro Ser Gly Trp
Pro Ser Asn Glu
Pro Ser Gln Asp
Pro Ser Trp Gly
Pro Thr Asp Asn
Pro Thr Asn Asp
Pro Val Cys Gln
Pro Val Gln Cys
Pro Trp Gly Ser
Pro Trp Ser Gly
Gln Ala Met Pro
Gln Ala Asn Asn
Gln Ala Pro Met
Gln Cys Pro Val
Gln Cys Val Pro
Gln Asp Pro Ser
Gln Asp Ser Pro
Gln Gly Asn Gln
Gln Gly Gln Asn
Gln Met Ala Pro
Gln Met Pro Ala
Gln Asn Ala Asn
Gln Asn Gly Gln
Gln Asn Asn Ala
Gln Asn Gln Gly
Gln Pro Ala Met
Gln Pro Cys Val
Gln Pro Asp Ser
Gln Pro Met Ala
Gln Pro Ser Asp
Gln Pro Val Cys
Gln Gln Gly Asn
Gln Gln Asn Gly
Gln Ser Asp Pro
Gln Ser Pro Asp
Gln Val Cys Pro
Gln Val Pro Cys
Arg Ala Cys Pro
Arg Ala Pro Cys
Arg Cys Ala Pro
Arg Cys Pro Ala
Arg Pro Ala Cys
Arg Pro Cys Ala
Ser Asp Pro Gln
Ser Asp Gln Pro
Ser Glu Asn Pro
Ser Glu Pro Asn
Ser Gly Pro Trp
Ser Gly Trp Pro
Ser Asn Glu Pro
Ser Asn Pro Glu
Ser Pro Asp Gln
Ser Pro Glu Asn
Ser Pro Gly Trp
Ser Pro Asn Glu
Ser Pro Gln Asp
Ser Pro Trp Gly
Ser Gln Asp Pro
Ser Gln Pro Asp
Ser Trp Gly Pro
Ser Trp Pro Gly
Thr Asp Asn Pro
Thr Asp Pro Asn
Thr Asn Asp Pro
Thr Asn Pro Asp
Thr Pro Asp Asn
Thr Pro Asn Asp
Val Cys Pro Gln
Val Cys Gln Pro
Val Pro Cys Gln
Val Pro Gln Cys
Val Gln Cys Pro
Val Gln Pro Cys
Trp Gly Pro Ser
Trp Gly Ser Pro
Trp Pro Gly Ser
Trp Pro Ser Gly
Trp Ser Gly Pro
Trp Ser Pro Gly
PC(6:2/6:2)
Lucuminamide
Tauro-18-carboxy-19,20-dinor-LTB
[(1S)-1-[[(2-Fluoro-6-nitrobenzoyl)phenylamino]carbonyl]propyl]carbamic acid 1,1-dimethylethyl ester
3,4-Dimethoxy-N-[3-(1,2,3,4-tetrahydro-7-isoquinolinylcarbamoyl)b enzyl]benzamide
magnesium 1,4-bis(2-ethylhexyl) 2-sulphonatosuccinate
N4-BENZOYL-5-O-TERT-BUTYLDIMETHYLSILYL-2-DEOXYCYTIDINE
5-O-TBDMS-N4-Benzoyl-2-deoxycytidine is a modified nucleoside. 5-O-TBDMS-N4-Benzoyl-2-deoxycytidine can be used in the synthesis of deoxyribonucleic acid or nucleic acid.
Paroxetine maleate
D004791 - Enzyme Inhibitors > D065607 - Cytochrome P-450 Enzyme Inhibitors > D065690 - Cytochrome P-450 CYP2D6 Inhibitors D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D017367 - Selective Serotonin Reuptake Inhibitors D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D000928 - Antidepressive Agents D018377 - Neurotransmitter Agents > D014179 - Neurotransmitter Uptake Inhibitors D049990 - Membrane Transport Modulators
N-[2-[4-(cyclohexylcarbamoylsulfamoyl)phenyl]ethyl]-6-methylpyrazine-2-carboxamide
3-(5-[(FLUOREN-9-YLMETHOXY)CARBONYLAMINO]PENTYLOXY)BENZOIC ACID
Thiopropazate
N - Nervous system > N05 - Psycholeptics > N05A - Antipsychotics > N05AB - Phenothiazines with piperazine structure C78272 - Agent Affecting Nervous System > C267 - Antiemetic Agent > C740 - Phenothiazine C78272 - Agent Affecting Nervous System > C29710 - Antipsychotic Agent
Thiourea, N-[2-(5,6-dimethyl-1H-benzimidazol-2-yl)ethyl]-N-(4-methoxyphenyl)-N-(3-pyridinylmethyl)- (9CI)
Thiourea, N-[2-(5,6-dimethyl-1H-benzimidazol-2-yl)ethyl]-N-(3-methoxyphenyl)-N-(3-pyridinylmethyl)- (9CI)
Thiourea, N-[2-(5,6-dimethyl-1H-benzimidazol-2-yl)ethyl]-N-(2-methoxyphenyl)-N-(3-pyridinylmethyl)- (9CI)
Thiazol-5-ylmethyl (2R,5R)-5-amino-1,6-diphenylhexan-2-ylcarbamate hydrochloride
Selonsertib
C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C61074 - Serine/Threonine Kinase Inhibitor D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors
(2S,5S)-1-(4-(tert-butyl)phenyl)-2,5-bis(4-nitrophenyl)pyrrolidine
4-[4-[4-[4-fluoro-3-(trifluoromethyl)phenyl]-1-methylimidazol-2-yl]piperidin-1-yl]-1H-pyrazolo[3,4-d]pyrimidine
C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C61074 - Serine/Threonine Kinase Inhibitor
N-(4-Fluorobenzyl)-3-oxo-1,1-diphenyltetrahydro-1H-oxazolo[3,4-a]pyrazine-7(3H)-carboxamide
D000890 - Anti-Infective Agents > D023303 - Oxazolidinones SHA 68 is a potent and selective non-peptide neuropeptide S receptor (NPSR) antagonist with IC50s of 22.0 and 23.8 nM for NPSR Asn107 and NPSR Ile107, respectively. SHA 68 has limited the blood-brain barrier (BBB) penetration and the activity in neuralgia[1][2].
(2E)-9-{[3,6-dideoxy-4-O-(1H-indol-3-ylcarbonyl)-alpha-L-arabino-hexopyranosyl]oxy}non-2-enoic acid
N-(9-ethyl-3-carbazolyl)-2-[[4-ethyl-5-(2-furanyl)-1,2,4-triazol-3-yl]thio]acetamide
(2E,8R)-8-{[3,6-dideoxy-4-O-(1H-indol-3-ylcarbonyl)-alpha-L-arabino-hexopyranosyl]oxy}non-2-enoic acid
4-(2-Aminoethoxy)-N-(3-Chloro-2-Ethoxy-5-Piperidin-1-Ylphenyl)-3,5-Dimethylbenzamide
1-((1R)-1-(Hydroxymethyl)-3-{6-[(3-phenylpropanoyl)amino]-1H-indol-1-YL}propyl)-1H-imidazole-4-carboxamide
(S)-2-(Phosphonoxy)caproyl-L-leucyl-P-nitroanilide
N-[4-Chloro-3-(pyridin-3-yloxymethyl)-phenyl]-3-fluoro-
Glisentide
C78276 - Agent Affecting Digestive System or Metabolism > C29711 - Anti-diabetic Agent > C97936 - Sulfonylurea Antidiabetic Agent
[10,13-dimethyl-17-(1-oxidopyridin-1-ium-3-yl)-2,3,4,7,8,9,11,12,14,15-decahydro-1H-cyclopenta[a]phenanthren-3-yl] hydrogen sulfate
2-Cyano-2-[3-[4-(phenylmethyl)-1-piperazinyl]-2-quinoxalinyl]acetic acid 2-methoxyethyl ester
1-(1-tert-butyl-5-tetrazolyl)-N-[(4-chlorophenyl)methyl]-N-(2-oxolanylmethyl)-1-thiophen-2-ylmethanamine
2-(2,4-Dimethoxyphenyl)-5-methyl-4-[[4-(4-quinazolinyl)-1-piperazinyl]methyl]oxazole
5-(6,7-diethoxy-4-oxo-2-sulfanylidene-1H-quinazolin-3-yl)-N-(2-furanylmethyl)pentanamide
2-{[4-(1,3-Benzodioxol-5-ylmethyl)piperazin-1-yl]carbonyl}-7-methoxyfuro[2,3-b]quinoline
N-(2,3-dihydro-1,4-benzodioxin-6-yl)-2-[4-(2,5-dimethylphenyl)sulfonyl-1-piperazinyl]acetamide
[5-[2-(3,4-Dimethoxyphenyl)quinolin-4-yl]-1,3,4-oxadiazol-2-yl]methyl 2-methylcyclopropane-1-carboxylate
6-N-(furan-2-ylmethyl)-4-N-(4-methoxyphenyl)-2-N-[(E)-(4-methoxyphenyl)methylideneamino]-1,3,5-triazine-2,4,6-triamine
2-(3-Chlorophenyl)-9-[4-(2-pyrazinyl)-1-piperazinyl]-5,6,7,8-tetrahydropyrazolo[5,1-b]quinazoline
1-[2-(5,6-dimethyl-1H-benzimidazol-2-yl)ethyl]-3-(2-methoxyphenyl)-1-(3-pyridinylmethyl)thiourea
N-[(E)-[3-(1-Benzofuran-2-yl)-1-phenylpyrazol-4-yl]methylideneamino]-1H-indole-3-carboxamide
N-[(E)-(4a,9-dihydroxy-3-prop-2-enyl-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-ylidene)amino]benzamide
8-methoxy-3-[(E)-[4-methoxy-3-(1-pyrrolidinylmethyl)phenyl]methylideneamino]-2-methyl-5H-pyrimido[5,4-b]indol-4-one
(2R,3R,3aS,9bS)-1-[(2,5-difluorophenyl)methyl]-3-(hydroxymethyl)-2-(morpholine-4-carbonyl)-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizin-6-one
(1R,9S,10S,11S)-10-(hydroxymethyl)-5-(4-methoxyphenyl)-12-methyl-6-oxo-N-phenyl-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide
(2S,3S,3aR,9bR)-1-[(2,5-difluorophenyl)methyl]-3-(hydroxymethyl)-2-[4-morpholinyl(oxo)methyl]-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizin-6-one
(3R)-3-(2-hydroxyethyl)-N,N-dimethyl-2-(1-oxopropyl)-4-[3-(5-pyrimidinyl)phenyl]-1,3-dihydropyrrolo[3,4-c]pyridine-6-carboxamide
(1S,9R,10R,11R)-10-(hydroxymethyl)-5-(4-methoxyphenyl)-12-methyl-6-oxo-N-phenyl-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide
[(2S,3S)-2-(hydroxymethyl)-3-[4-[(E)-prop-1-enyl]phenyl]-6-(3,3,3-trifluoropropyl)-1,6-diazaspiro[3.3]heptan-1-yl]-pyridin-2-ylmethanone
[(2R,3R)-2-(hydroxymethyl)-3-[4-[(E)-prop-1-enyl]phenyl]-6-(3,3,3-trifluoropropyl)-1,6-diazaspiro[3.3]heptan-1-yl]-pyridin-2-ylmethanone
(1S,19S)-9,9,16,16-tetramethyl-14-oxido-8-oxa-23,25-diaza-14-azoniaheptacyclo[17.5.2.01,17.03,15.04,13.07,12.019,23]hexacosa-2,4(13),5,7(12),10,14-hexaene-24,26-dione
(1S,3S,12Z)-1-hydroxy-14,14,21,21-tetramethyl-22-oxa-5,11,16-triazahexacyclo[13.11.0.03,11.05,9.017,26.018,23]hexacosa-8,12,15,17(26),18(23),19,24-heptaene-4,10-dione
estrone 3-O-(beta-D-glucuronide)(1-)
A steroid glucuronide anion that is the conjugate base of estrone 3-O-(beta-D-glucuronide) arising from deprotonation of the carboxylic acid function; major species at pH 7.3.
(6S)-5,6,7,8-tetrahydrofolic acid
A derivative of folic acid in which the pteridine ring is fully reduced; it is the parent compound of a variety of coenzymes that serve as carriers of one-carbon groups in metabolic reactions.
BPTU
BPTU (BMS-646786) is a non-nucleotide P2Y1 receptor allosteric antagonist with antithrombotic activity. BPTU is able to block the P2Y1 receptor located at the neuromuscular junction of the gastrointestinal tract[1][2].
PQR620
PQR620 is an orally bioavailable and selective brain penetrant inhibitor of mTORC1/2[1]. PQR620 is an orally bioavailable and selective brain penetrant inhibitor of mTORC1/2[1].
Samelisant
Samelisant (SUVN-G3031) is a potent and selective histamine H3 receptor (H3R) inverse agonist with good brain penetration and oral bioavailability. Samelisant has a similar binding affinity towards human (hH3R; Ki=8.7 nM) and rat (rH3R;Ki=9.8 nM) H3R indicating no inter-species differences. Samelisant can be used for the research of sleep-related disorders[1].